UNDERUTILIZATION OF LIPID-LOWERING DRUGS IN OLDER PERSONS WITH PRIOR MYOCARDIAL-INFARCTION AND A SERUM LOW-DENSITY-LIPOPROTEIN CHOLESTEROL GREATER-THAN-125 MG DL/
Ws. Aronow, UNDERUTILIZATION OF LIPID-LOWERING DRUGS IN OLDER PERSONS WITH PRIOR MYOCARDIAL-INFARCTION AND A SERUM LOW-DENSITY-LIPOPROTEIN CHOLESTEROL GREATER-THAN-125 MG DL/, The American journal of cardiology, 82(5), 1998, pp. 668
A prospective study of 500 consecutive persons (aged 60 years with Q-w
ave myocardial infarction admitted to a long-term health care facility
) investigated the prevalence of the use of a lipid-lowering drug at t
he time of admission in persons with a fasting serum low-density lipop
rotein (LDL) cholesterol >125 mg/dl measured the day after admission.
The prevalence of a lipid-lowering drug in persons with myocardial inf
arction and an LDL cholesterol >125 mg/dl was 7% (11 of 153 persons) i
n persons 60 to 80 years of age and 3% (6 of 182 persons) in persons 8
1 to 100 years of age.